Stem Cells Market market is expected to grow at a CAGR of 15.1% during the forecasted period | Evolve Business Intelligence

As per the study initiated by Evolve Business Intelligence, the global Stem Cells Market size accounted for USD 18.2 Billion in 2023, growing at a CAGR of 15.1% from 2023 to 2033. Stem cells are undifferentiated cells with the unique ability to develop into various specialized cell types in the body. They play a crucial role in the development, growth, and repair of tissues. There are two main types of stem cells: embryonic stem cells, which are derived from embryos, and adult or somatic stem cells, which are found in various tissues throughout the body.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021454

Stem cells have the potential to regenerate and repair damaged tissues and organs. This capability has led to the development of innovative treatments for various diseases and injuries, such as heart disease, diabetes, spinal cord injuries, and neurodegenerative disorders. Ongoing research in the field of stem cell biology and regenerative medicine has fueled the market. Scientists are exploring new ways to use stem cells for therapeutic purposes and to understand their fundamental properties. The rising incidence of chronic diseases, including cardiovascular diseases, diabetes, and neurodegenerative disorders, has increased the demand for novel and effective treatments. Stem cell therapies offer potential solutions for these conditions.

Key Players
Some of the major Stem Cells Market players holding high market shares include Advanced Cell Technology Inc., STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., and CellGenix GmbH. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include PromoCell GmbH, Kite Pharma, Lonza, Cellartis AB, Angel Biotechnology, Brainstorm Cell Therapeutics, Celgene Corporation, Osiris Therapeutics, Genea Biocells, Bioheart Inc., Waisman Biomanufacturing, Tigenix, Caladrius Biosciences, Gamida Cell

For More Information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021454

Segmental Analysis
Based on cell source, the Stem Cells market is segmented into Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, Other. The largest segment of the stem cells market based on cell source is adipose tissue-derived mesenchymal stem cells (MSCs). This is due to several factors, including the ease of harvesting adipose tissue, the abundance of MSCs in adipose tissue, and the ability of adipose tissue-derived MSCs to differentiate into a variety of cell types. Adipose tissue is a readily available and abundant source of MSCs. MSCs can be easily harvested from adipose tissue using minimally invasive procedures, such as liposuction. This makes adipose tissue a more convenient and less invasive source of MSCs than other sources, such as bone marrow.
Based on Application, the Stem Cells market is Cancer, Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Disease, and others. The largest segment of the stem cell market based on application is musculoskeletal disorders. This is due to the potential of stem cells to repair and regenerate damaged musculoskeletal tissues. Musculoskeletal disorders are a leading cause of disability worldwide. They affect millions of people and can cause a great deal of pain and suffering. Current treatments for musculoskeletal disorders are often limited and can have side effects. Stem cells offer a potential new approach to treating these disorders.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.